Glossary

Tracking participant compliance with trial protocols and treatment regimens.

A publicly accessible database where clinical trials are registered for transparency.

An outcome based on participant self-reports, such as pain or quality of life.

An outcome measured without bias, such as blood pressure or lab results.

Gradually adjusting the dose of a drug to find the optimal amount for safety and efficacy.

An assessment of whether an adverse event is related to the investigational treatment.

The proportion of participants who leave the trial before completion.

A trial design where only the participants are unaware of their treatment group assignment.

The point at which all trial data is finalized and cannot be altered.

The demographics and clinical data of participants at the start of a trial.

Adherence to trial regulations, protocols, and ethical guidelines.

A biological marker evaluated to assess its potential role in future research or treatment.

Instances where the trial's planned procedures are not followed.

The process of determining the number of participants needed to achieve reliable results.